Workshop: Unlocking opportunities in the Netherlands

The Netherlands is one of the most strategically relevant markets for Belgian healthtech companies looking to expand internationally. With a mature and digitally advanced healthcare system, strong adoption of innovation and a growing focus on digital-first and hybrid care, the Dutch market offers significant opportunities—but also its own reimbursement pathways, procurement processes and commercial dynamics.

Join Biovia and PwC for an afternoon session focused on the practicalities of entering and growing in the Dutch healthtech market. 

Designed for Belgian healthtech start-ups and scale-ups active in medtech, digital health, software, AI, connected devices and care platforms, the session will bring together market insights, practical guidance and real-world perspectives on building a presence in the Netherlands. 

What to expect

The session will cover the key elements Belgian healthtech companies need to consider when entering or expanding in the Dutch market:

• The Dutch healthtech market: market trends, digital health adoption and key buyer segments, including hospitals, GPs, insurers, municipalities and home care
• Reimbursement and market access: reimbursement routes, hospital procurement, contracting with insurers, evidence expectations and pricing strategies
• The investment landscape: Dutch and Benelux healthtech funding, investor expectations and what makes a Belgian company attractive to Dutch investors
• Market entry in practice: insights from a healthtech company with experience entering the Dutch market
• Legal, tax and regulatory considerations: company set-up, MDR/SaMD, the AI Act and data protection
• Ecosystem and partnership opportunities: key organisations, regional agencies, hospitals and insurers, as well as opportunities for pilots and soft-landing

The program will conclude with a panel Q&A. 

Who should attend?

This session is aimed at:

• Belgian healthtech start-ups and scale-ups exploring or preparing expansion into the Netherlands
• Founders, CEOs, COOs and commercial leads evaluating the Dutch market
• Business development and strategy leads
• Companies already active in the Netherlands that want to strengthen their reimbursement, investor or ecosystem traction

What you will take away

By the end of the session, you will have:

• A clearer understanding of the Dutch healthtech market and its opportunities
• Practical insights into reimbursement, procurement and contracting pathways
• A better understanding of Dutch investor expectations
• An overview of relevant Dutch ecosystem players and potential entry points
• Opportunities to connect with PwC, Cbusinez, investors and Dutch ecosystem players
• Practical guidance to help shape your first 180 days in the Netherlands 

Registration is open to Biovia members only.

For more information, please contact rita.prota@biovia.be.